1. Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis
- Author
-
Norinne Lacerda-Queiroz, Marco Antônio Campos, Mauro M. Teixeira, Antônio Lúcio Teixeira, Graciela Kunrath Lima, Milene Alvarenga Rachid, Márcia Carvalho Vilela, Vinicius Sousa Pietra Pedroso, Aline Silva de Miranda, Erna Geessien Kroon, and David Henrique Rodrigues
- Subjects
Male ,0301 basic medicine ,Dihydropyridines ,Chemokine ,Immunology ,Neuroscience (miscellaneous) ,Vascular permeability ,Herpesvirus 1, Human ,Platelet Membrane Glycoproteins ,Severity of Illness Index ,Receptors, G-Protein-Coupled ,Pathogenesis ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,Meningoencephalitis ,medicine ,Animals ,Immunology and Allergy ,Mice, Knockout ,Pharmacology ,Platelet-activating factor ,biology ,Imidazoles ,Brain ,Herpes Simplex ,medicine.disease ,Mice, Inbred C57BL ,030104 developmental biology ,chemistry ,biology.protein ,CXCL9 ,030217 neurology & neurosurgery ,Intravital microscopy - Abstract
Herpes simplex virus type 1 (HSV-1) is a human pathogen that may cause severe encephalitis. The exacerbated immune response against the virus contributes to the disease severity and death. Platelet activating factor (PAF) is a mediator capable of inducing increase in vascular permeability, production of cytokines on endothelial cells and leukocytes. We aimed to investigate the activation of PAF receptor (PAFR) and its contribution to the severity of the inflammatory response in the brain following HSV-1 infection. C57BL/6 wild-type (WT) and PAFR deficient (PAFR-/-) mice were inoculated intracranially with 104 plaque-forming units (PFU) of HSV-1. Visualization of leukocyte recruitment was performed using intravital microscopy. Cells infiltration in the brain tissue were analyzed by flow cytometry. Brain was removed for chemokine assessment by ELISA and for histopathological analysis. The pharmacological inhibition by the PAFR antagonist UK-74,505 was also analyzed. In PAFR-/- mice, there was delayed lethality but no difference in viral load. Histopathological analysis of infected PAFR-/- mice showed that brain lesions were less severe when compared to their WT counterparts. Moreover, PAFR-/- mice showed less TCD4+, TCD8+ and macrophages in brain tissue. This reduction of the presence of leukocytes in parenchyma may be mechanistically explained by a decrease in leukocytes rolling and adhesion. PAFR-/- mice also presented a reduction of the chemokine CXCL9 in the brain. In addition, by antagonizing PAFR, survival of C57BL/6 infected mice increased. Altogether, our data suggest that PAFR plays a role in the pathogenesis of experimental HSV-1 meningoencephalitis, and its blockade prevents severe disease manifestation.
- Published
- 2016
- Full Text
- View/download PDF